The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, dose-finding, phase Ib study to assess the safety, tolerability of nesuparib (JPI-547), a dual inhibitor of PARP/TNKS, in combination with modified FOLFIRINOX (mFOLFIRINOX) and gemcitabine-nab-paclitaxel (GemAbraxane) in patients with locally advanced and metastatic pancreatic cancer.
 
Do-Youn Oh
Consulting or Advisory Role - Abbvie; Alligtor Bioscience AB; Arcus Biosciences; ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Basilea; Bayer; BeiGene; Celgene; Eutilex; Genentech/Roche; Halozyme; Hana Pharm; Idience; IQVIA; J-Pharma; LG Chem; Merck Serono; Mirati Therapeutics; Moderna Therapeutics; MSD Oncology; Novartis; Taiho Pharmaceutical; Turning Point Therapeutics; Yuhan; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; BeiGene; Handok; Lilly; MSD; Novartis; SERVIER
 
Jin Won Kim
Consulting or Advisory Role - AstraZeneca; BeiGene Beijing; BeiGene Beijing; BeyondBIO; Bristol-Myers Squibb/Celgene; Eisai; GC Cell; MSD; Ono Pharmaceutical; Roche; Sanofi; Servier; TCUBEit
Research Funding - Boryung Pharmaceuticals; Samyang
 
Joon Oh Park
Consulting or Advisory Role - ABL Bio; Adicet Bio; Arcus Biosciences; AstraZeneca; Celgene; ImmuneOncia; Intocell; MediRama; Merck Serono; SERVIER
Research Funding - ABL Bio; Celgene; Eutilex; medpacto; SERVIER
Travel, Accommodations, Expenses - Minneamrita Therapeutics
 
Hye Jin Choi
No Relationships to Disclose
 
Jeesun Yoon
No Relationships to Disclose
 
Minsu Kang
No Relationships to Disclose
 
Jung Yong Hong
No Relationships to Disclose
 
Choong-kun Lee
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Roche; SERVIER
Speakers' Bureau - Boryung Pharmaceuticals; Celgene/Bristol-Myers Squibb; Handok; Novartis; Sanofi
Research Funding - Boryung Pharmaceuticals (Inst); GC Biopharma (Inst); Lunit (Inst); Ono Pharmaceutical (Inst)
 
Hyesoo Kwon
Employment - Onconic Therapeutics
 
Eunji Kim
Employment - Onconic Therapeutics
 
Hyunju Cha
Employment - Onconic Therapeutics
Stock and Other Ownership Interests - Onconic Therapeutics
 
Jun Kim
Employment - Onconic Therapeutics
 
John Kim
Employment - Onconic Therapeutics
Leadership - Onconic Therapeutics